非骨水泥假体全髋关节置换术治疗Hartofilakidis C1与C2型高脱位髋关节发育不良在至少10年随访中显示相似的生存率与临床功能
该回顾性研究纳入2002至2011年间接受非骨水泥假体全髋关节置换术的84例Hartofilakidis C型髋关节发育不良患者,至少随访10年(平均13年,范围10至19年)。比较C1与C2型髋的生存率、临床功能、影像学结果及并发症,发现两组15年累积生存率、Harris髋关节评分及并发症无差异,但C2型术前下肢长度差异更严重且需要更高比例、更长的转子下短缩横行截骨。
要点
- C1与C2型髋15年累积生存率(以任何再手术为终点)分别为93.1%与90.8%,无差异。
- C2型术前下肢长度差异更大(66.9 vs 42.5 mm),需要转子下短缩横行截骨的比例更高(84.6% vs 36.2%)。
- 两组末次Harris髋关节评分(87.1 vs 86.1%)、脱位率(5.2% vs 11.5%)等并发症无差异。
核心结论
- 采用非骨水泥髋臼杯置于接近解剖髋臼中心、非骨水泥股骨柄联合转子下短缩横行截骨,Hartofilakidis C1与C2型髋的全髋关节置换术显示出相似的生存率、临床功能和并发症。
研究设计与样本
- 回顾性研究,纳入2002至2011年间接受全髋关节置换术的84例Hartofilakidis C型髋,至少随访10年(平均13年,范围10至19年)。
主要发现
- C1与C2型髋15年累积Kaplan-Meier生存率(以任何再手术为终点)分别为93.1%与90.8%,以无菌性松动合并假体周围关节感染为终点分别为93.1%与96.2%,以无菌性松动为终点分别为94.8%与96.2%,均无差异。
- 末次Harris髋关节评分C1组为87.1%,C2组为86.1%;至解剖旋转中心的垂直距离分别为6.1 mm与6.0 mm,水平距离分别为11.5 mm与10.3 mm;术后下肢长度差异分别为11.2 mm与15.5 mm。
- 脱位率C1组为5.2%,C2组为11.5%;股骨柄无菌性松动率分别为6.9%与7.7%;假体周围骨折率分别为3.4%与7.7%;术中股骨骨折率分别为32.8%与23.1%。
- C2型髋术前下肢长度差异更严重(66.9 vs 42.5 mm),需要转子下短缩横行截骨的比例更高(84.6% vs 36.2%),且截骨长度更长(33.7 vs 26.47 mm)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to determine the differences in survivorship, clinical function, and complications among patients who have Hartofilakidis Type C1 or C2 developmental dysplasia of the hips and underwent total hip arthroplasty (THA) with cementless implants. METHODS: This retrospective study identified 84 Hartofilakidis Type C hips that underwent THA between 2002 and 2011 with a minimum 10-year follow-up (mean, 13 years, range, 10 to 19 years). Survivorship, latest Harris Hip Scores and satisfaction levels, radiographic outcomes (eg, implant stability, rate and length of subtrochanteric shortening transverse osteotomy, leg-length discrepancy, cup position, and orientation), as well as complications (eg, dislocation, periprosthetic fracture, periprosthetic joint infection) were compared to analyze the differences between Hartofilakidis C1 and C2 hips. RESULTS: Between C1 and C2 hips, no difference existed in the 15-year cumulative Kaplan-Meier survivorship, with the endpoint defined as any reoperation (93.1 versus 90.8%), aseptic loosening combined with periprosthetic joint infection (93.1 versus 96.2%), or aseptic loosening (94.8 versus 96.2%), latest Harris Hip Score (87.1 versus 86.1%), vertical (6.1 versus 6.0 mm) and horizontal (11.5 versus 10.3 mm) distance to the anatomic center of rotation, postoperative leg length discrepancy (11.2 versus 15.5 mm), dislocation (5.2 versus 11.5%), stem aseptic loosening (6.9 versus 7.7%), periprosthetic fracture (3.4 versus 7.7%), and intraoperative femoral fracture (32.8 versus 23.1%). However, Type C2 hips demonstrated more severe preoperative leg length discrepancy (66.9 versus 42.5 mm) and required a higher percentage of subtrochanteric shortening transverse osteotomies (84.6 versus 36.2%) that were longer (33.7 versus 26.47 mm) than the Type C1 hips. CONCLUSION: With cementless cups positioned near the anatomic acetabular center and cementless stems combined with subtrochanteric shortening transverse osteotomies, THAs for the Hartofilakidis Type C1 and C2 hips demonstrated similar survivorship, clinical function, and complications.
引用
- Huang Y, Zhou Y, Shao H, et al. Total Hip Arthroplasties for Hartofilakidis Type C1 and C2 High Hip Dislocations Demonstrate Similar Survivorship and Clinical Function at Minimum 10-year Follow-up With Cementless Implants. J Arthroplasty. 2022. PMID: 35709909. doi:10.1016/j.arth.2022.06.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。